Free Trial
NASDAQ:ZYXI

Zynex (ZYXI) Stock Price, News & Analysis

Zynex logo
$1.48 -0.01 (-0.34%)
As of 01:15 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About Zynex Stock (NASDAQ:ZYXI)

Key Stats

Today's Range
$1.44
$1.50
50-Day Range
$1.26
$2.58
52-Week Range
$1.23
$9.42
Volume
70,287 shs
Average Volume
246,542 shs
Market Capitalization
$44.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.90
Consensus Rating
Hold

Company Overview

Zynex Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
50th Percentile Overall Score

ZYXI MarketRank™: 

Zynex scored higher than 50% of companies evaluated by MarketBeat, and ranked 618th out of 954 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Zynex has received a consensus rating of Hold. The company's average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

  • Upside Potential

    Zynex has a consensus price target of $4.90, representing about 234.5% upside from its current price of $1.47.

  • Amount of Analyst Coverage

    Zynex has only been the subject of 3 research reports in the past 90 days.

  • Read more about Zynex's stock forecast and price target.
  • Earnings Growth

    Earnings for Zynex are expected to grow by 135.00% in the coming year, from $0.20 to $0.47 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Zynex is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Zynex is -1.56, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Zynex has a P/B Ratio of 1.31. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Zynex's valuation and earnings.
  • Percentage of Shares Shorted

    20.11% of the float of Zynex has been sold short.
  • Short Interest Ratio / Days to Cover

    Zynex has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Zynex has recently increased by 1.42%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Zynex does not currently pay a dividend.

  • Dividend Growth

    Zynex does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    20.11% of the float of Zynex has been sold short.
  • Short Interest Ratio / Days to Cover

    Zynex has a short interest ratio ("days to cover") of 12.3, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Zynex has recently increased by 1.42%, indicating that investor sentiment is decreasing.
  • News Sentiment

    Zynex has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Zynex this week, compared to 9 articles on an average week.
  • Search Interest

    4 people have searched for ZYXI on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Zynex insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    49.28% of the stock of Zynex is held by insiders. A high percentage of insider ownership can be a sign of company health.

  • Percentage Held by Institutions

    Only 29.68% of the stock of Zynex is held by institutions.

  • Read more about Zynex's insider trading history.
Receive ZYXI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Zynex and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ZYXI Stock News Headlines

Zynex announces new executive team
Trump’s national nightmare is here
Porter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger the biggest forced rotation of capital since World War II. They reveal why Trump is mobilizing America’s tech giants… and name the two stocks most likely to soar as trillions shift behind the scenes.tc pixel
Zynex welcomes Steve Dyson as CEO, adds to leadership team
Zynex Q2 Revenue Drops 55%
See More Headlines

ZYXI Stock Analysis - Frequently Asked Questions

Zynex's stock was trading at $8.01 at the beginning of 2025. Since then, ZYXI shares have decreased by 81.7% and is now trading at $1.4650.

Zynex Inc. (NASDAQ:ZYXI) issued its earnings results on Monday, April, 28th. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.24) by $0.09. The business had revenue of $26.58 million for the quarter, compared to the consensus estimate of $30.83 million. Zynex had a negative trailing twelve-month return on equity of 78.54% and a negative net margin of 19.79%.
Read the conference call transcript
.

Zynex's top institutional shareholders include Janney Montgomery Scott LLC (1.46%), Arrowstreet Capital Limited Partnership (0.82%), Geode Capital Management LLC (0.63%) and RBF Capital LLC (0.50%). Insiders that own company stock include Thomas Sandgaard, Joshua R Disbrow, Anna Lucsok and Daniel J Moorhead.
View institutional ownership trends
.

Shares of ZYXI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Zynex investors own include American Water Works (AWK), Waste Connections (WCN), The RMR Group (RMR), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), AU Optronics (AUOTY) and Humana (HUM).

Company Calendar

Last Earnings
4/28/2025
Today
9/15/2025
Next Earnings (Estimated)
10/30/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED PRODUCTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ZYXI
CIK
846475
Fax
N/A
Employees
770
Year Founded
N/A

Price Target and Rating

High Price Target
$8.00
Low Price Target
$3.00
Potential Upside/Downside
+231.1%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.94)
Trailing P/E Ratio
N/A
Forward P/E Ratio
7.40
P/E Growth
N/A
Net Income
$2.99 million
Net Margins
-19.79%
Pretax Margin
-15.83%
Return on Equity
-78.54%
Return on Assets
-16.70%

Debt

Debt-to-Equity Ratio
0.56
Current Ratio
0.62
Quick Ratio
0.45

Sales & Book Value

Annual Sales
$192.35 million
Price / Sales
0.23
Cash Flow
$0.24 per share
Price / Cash Flow
6.06
Book Value
$1.12 per share
Price / Book
1.32

Miscellaneous

Outstanding Shares
30,300,000
Free Float
15,367,000
Market Cap
$44.84 million
Optionable
Optionable
Beta
1.02

Social Links

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

This page (NASDAQ:ZYXI) was last updated on 9/15/2025 by MarketBeat.com Staff
From Our Partners